QIAGEN Drives The Development Of Companion Diagnostics With Two Key Appointments
QIAGEN has announced the appointment of two high level members, Dr Pia Garguilo and Richard Watts, to the recently formed Pharma Business Development team.
Read MoreSearch Results for: leukemia
PerkinElmer Enters Into Agreement to Acquire Signature Genomic Laboratories
Posted by Clinical Lab Products | Apr 16, 2010 | Cancer, Miscellaneous |
PerkinElmer Inc has announced that it has entered into a definitive agreement to acquire Signature Genomic Laboratories LLC, a diagnostic genetic testing company based in Spokane, Wash.
Read MoreTrovaGene NPM1 Technology Part of LabCorps AML Cancer Testing
Posted by Clinical Lab Products | Apr 2, 2010 | Cancer, Miscellaneous |
TrovaGene Inc–formerly Xenomics Inc– developer of transrenal molecular diagnostics, announced that LabCorp and InVivoScribe Technologies have notified the company that they have begun laboratory testing services for the detection of NPM1 mutations for the diagnosis of acute myelogenous leukemia (AML).
Read MoreGenome-Sequencing Is Profiling Responsiveness to Treatment for Advanced Breast Cancer
Posted by Clinical Lab Products | Mar 30, 2010 | Cancer, Miscellaneous |
Tumors biopsied from women with invasive breast cancer are having their genomes sequenced in an attempt to develop a DNA profile that one day may identify ahead of time the patients who will most likely respond to chemotherapy with an aromatase inhibitor.
Read MoreGenoptix Announces National Three-Year Agreement With Aetna
Posted by Clinical Lab Products | Mar 1, 2010 | Cancer, Miscellaneous |
Genoptix Inc has announced that it will participate in Aetna’s (AET) national provider network to offer specialized laboratory and comprehensive diagnostic services designed to optimize the care of patients suffering from hematomalignancies, or cancers of the blood and bone marrow, including leukemia and lymphoma.
Read More